The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19. Author's reply
- PMID: 33507321
- PMCID: PMC7840620
- DOI: 10.1007/s00134-020-06335-5
The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19. Author's reply
Conflict of interest statement
The authors have no financial or personal relationships with other people or organizations that could inappropriately influence (bias) their work.
Comment on
-
Ten reasons why corticosteroid therapy reduces mortality in severe COVID-19.Intensive Care Med. 2021 Mar;47(3):355-356. doi: 10.1007/s00134-020-06330-w. Epub 2021 Jan 2. Intensive Care Med. 2021. PMID: 33388793 Free PMC article. No abstract available.
References
-
- Villar J, Ferrando C, Martinez D, Ambros A, Munoz T, Soler JA, Aguilar G, Alba F, Gonzalez-Higueras E, Conesa LA, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respirat Med. 2020;8(3):267–276. doi: 10.1016/S2213-2600(19)30417-5. - DOI - PubMed
-
- Horby P, Lim WS, Emberson J, Mafham M, Bell J, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E (2020) Dexamethasone in hospitalized patients with Covid-19—preliminary report. N Engl J Med. 10.1056/NEJMoa2021436 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
